These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
3. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice. Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E; J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724 [TBL] [Abstract][Full Text] [Related]
4. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry. Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A; Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925 [TBL] [Abstract][Full Text] [Related]
5. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
6. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
8. A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial. Healey JS; Gula LJ; Birnie DH; Sterns L; Connolly SJ; Sapp J; Crystal E; Simpson C; Exner DV; Kus T; Philippon F; Wells G; Tang AS J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1313-6. PubMed ID: 22788915 [TBL] [Abstract][Full Text] [Related]
9. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
10. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245 [TBL] [Abstract][Full Text] [Related]
11. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523 [TBL] [Abstract][Full Text] [Related]
13. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy. Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892 [TBL] [Abstract][Full Text] [Related]
15. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
16. Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis. Barra S; Providência R; Duehmke R; Boveda S; Begley D; Grace A; Narayanan K; Tang A; Marijon E; Agarwal S Europace; 2018 Mar; 20(3):481-491. PubMed ID: 28666319 [TBL] [Abstract][Full Text] [Related]
17. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death. House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819 [TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M; Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524 [TBL] [Abstract][Full Text] [Related]
20. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]